Remdesivir: Drug has 'clear cut' power to fight coronavirus
It is also not clear who is benefiting. Is it allowing people who would have recovered anyway to do so more quickly? Or is it preventing people from needing treatment in intensive care? Did the drug work better in younger or older people? Or those with or without other diseases? Do patients have to be treated early when the virus is thought to peak in the body?
Prof Mahesh Parmar, the director of the MRC Clinical Trials Unit at UCL, who has overseen the trial in the EU, said:"Before this drug can be made more widely available, a number of things need to happen: the data and results need to be reviewed by the regulators to assess whether the drug can be licensed and then they need assessment by the relevant health authorities in various countries.
If a medicine can stop people needing intensive care then the risk of hospitals being overwhelmed is smaller, and there is less need for social distancing. "These data are promising, and given that we have no proven treatments yet for Covid, it may well lead to fast-track approval of remdesivir for treatment of Covid," said Prof Babak Javid, a consultant in infectious diseases at Cambridge University Hospitals.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus Drug Shows Promising Results, According to Drug MakerRemdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
Read more »
Company says drug proved effective against virus in US studyA biotech company says its experimental drug has proved effective against the new coronavirus in a major U.S. government study that put it to a strict test. Gilead Sciences’s remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since
Read more »
U.S. stocks jump on coronavirus drug hopes; oil surgesStocks advance amid renewed hopes for a coronavirus drug despite data showing the biggest economic contraction since 2008 in the first quarter.
Read more »
US FDA may announce emergency use of Gilead's coronavirus drugExperimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
Read more »
'Clear-cut' evidence coronavirus drug remdesivir works, Fauci saysNEW: Dr. Fauci says remdesivir study data shows 'a clear-cut, significant positive effect in diminishing the time to recovery;” adds remdesivir improved coronavirus recovery time from 15 days to 11 days.
Read more »
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
Read more »